85 related articles for article (PubMed ID: 11229852)
1. Transepithelial intestinal excretion of ciprofloxacin in humans.
Ramon J; Ben-Haim M; Shabtai M; Rubinstein E
Clin Infect Dis; 2001 Mar; 32(5):822-3. PubMed ID: 11229852
[TBL] [Abstract][Full Text] [Related]
2. Excretion of ciprofloxacin into the large bowel of the rabbit.
Ramon J; Dautrey S; Farinoti R; Carbon C; Rubinstein E
Antimicrob Agents Chemother; 1996 Jan; 40(1):11-3. PubMed ID: 8787870
[TBL] [Abstract][Full Text] [Related]
3. Effect of cholera toxin on intestinal elimination of ciprofloxacin in rabbits.
Musafija A; Barzilai A; Ramon J; Rubinstein E
Antimicrob Agents Chemother; 1998 Feb; 42(2):473-4. PubMed ID: 9527813
[TBL] [Abstract][Full Text] [Related]
4. Concentration of ciprofloxacin and metronidazole in human tissues during abdominal surgery.
Hopf G; Boecker R; Benz K; Stuetz G
J Chemother; 1989 Jul; 1(4 Suppl):562-4. PubMed ID: 16312533
[No Abstract] [Full Text] [Related]
5. Intratympanic ciprofloxacin and the human labyrinthine sampling model.
Becvarovski Z; Kartush JM; Bojrab DI
Laryngoscope; 2002 Apr; 112(4):686-8. PubMed ID: 12150524
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?
Lipman J; Gous AG; Mathivha LR; Tshukutsoane S; Scribante J; Hon H; Pinder M; Riera-Fanego JF; Verhoef L; Stass H
Intensive Care Med; 2002 Apr; 28(4):493-500. PubMed ID: 11967606
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses.
Odoul F; Le Guellec C; Giraut C; de Gialluly C; Marchand S; Paintaud G; Saux MC; Rolland JC; Autret-Leca E
Therapie; 2001; 56(5):519-24. PubMed ID: 11806288
[TBL] [Abstract][Full Text] [Related]
8. A study of ciprofloxacin kinetics in human muscle and gut tissues.
Viell B; Vestweber KH; Scholl H; Schaaf S
J Chemother; 1989 Jul; 1(4 Suppl):575-6. PubMed ID: 16312539
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers.
Washington CB; Hou SY; Campanella C; Hughes N; Brown S; Berner B
J Clin Pharmacol; 2005 Nov; 45(11):1236-44. PubMed ID: 16239356
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
Yu-Speight AW; Kern TJ; Erb HN
Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
[TBL] [Abstract][Full Text] [Related]
11. Intestinal elimination of ciprofloxacin in rabbits.
Ramon J; Dautrey S; Farinoti R; Carbon C; Rubinstein E
Antimicrob Agents Chemother; 1994 Apr; 38(4):757-60. PubMed ID: 8031042
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
13. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
14. The effect of Escherichia coli heat-stable toxin on the trans-epithelial intestinal elimination of ciprofloxacin in the rabbit.
Musafija A; Shtelman Y; Ramon J; Volk M; Segev S; Rubinstein E
J Antimicrob Chemother; 2001 May; 47(5):697-9. PubMed ID: 11328788
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
[TBL] [Abstract][Full Text] [Related]
16. The administration of ciprofloxacin during continuous renal replacement therapy: pilot study.
Hayakawa M; Fujita I; Iseki K; Gando S
ASAIO J; 2009; 55(3):243-5. PubMed ID: 19318919
[TBL] [Abstract][Full Text] [Related]
17. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
Khan MK; Khan MF
Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin skin titers in old age.
Meisel CW; Hopf G
J Chemother; 1989 Jul; 1(4 Suppl):567-70. PubMed ID: 16312535
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
[TBL] [Abstract][Full Text] [Related]
20. [Excretion of fluoroquinolones into saliva].
Kelentey BA; Kelentey BJ; Fekete I; Kozma J
Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
